Two novel diorganotin phosphonic diamides
3
2
119/117
1
Synthesis of Ligands
δ 1.12 (dd, 24H, JHH = 6.7 Hz, CH3), 1.25 [6H, J(
Sn, H) =
2
8
8.9 Hz, Sn(CH3)2], 2.60 (dd, 4H, JPH = 9.0 Hz, NH), 3.39 (m, 4H,
Synthesis of C6H5P(O)[NHCH(CH3)2]2
3
3
4
JHH = 6.4 Hz, CH), 7.45(dt, JHH = 7.4 Hz, JPH = 3.6, 4H, P–C6H5-
meta), 7.51 (dt, J = 7.3 Hz, J = 1.3 Hz, 2H, P–C H -para),
3
4
To a solution of PhP(O)Cl2 (0.820 g, 4.2 mmol) in CH3CN (20 ml), a
solution of iso-propylamine (0.994 g, 16.8 mmol) in CH3CN (10 ml)
was added dropwise at 0 C. After 12 h stirring, the solvent was
HH
PH
6 5
3
3
13
7.78 (dd, JPH = 14.0 Hz, JHH = 8.3, 4H, P–C6H5-ortho). C NMR
(CDCl3, ppm): δ 20.93 [s, Sn–CH3, J( Sn, C) = 1214.1 Hz], 25.70
◦
1
119
13
3
3
removed, the product was washed with distilled water and dried
(d, JPC = 2.3 Hz, CH3), 25.74 (d, JPC = 2.0 Hz, CH3), 43.29 (s, CH),
3 2
(
yield 0.45 g, 45%).
M.p. 154 C. Anal. calcd for C12H21N2OP: C, 59.98; H, 8.81; N,
128.49 (d, JPC = 13.5 Hz, P–C6H5-meta), 131.55 (d, JPC = 9.8 Hz,
◦
4
P–C6H5-ortho), 131.79 (d, JPC = 2.8 Hz, P–C6H5-para), 132.60 (d,
1
1
31
1
1.66. Found: C, 59.94; H, 8.80; N, 11.68%. H NMR (CDCl3, ppm):
JPC = 155.1 Hz, P–C6H5-ipso). P NMR (CDCl3, ppm): δ 18.37 (m).
3
3
119
−1
δ 1.09 (d, 6H, JHH = 6.4 Hz, CH3), 1.12 (d, 6H, JHH = 6.4 Hz,
Sn NMR (CD3OD, ppm): δ −118.56. IR (KBr, cm ): ν = 3240 (m,
3
CH3), 2.24 (m, 2H, NH), 3.43 (m, 2H, JHH = 6.6 Hz, CH), 7.41
N–H), 2945 (m), 1453 (w), 1417 (m), 1382 (w), 1138 (s, P O), 1103
(s), 1019 (w), 902 (w), 702 (w), 744 (w), 576 (w, Sn–C), 551 (m), 491
(w, Sn–O).
3
4
(
dt, JHH = 7.3 Hz, JPH = 3.1 Hz, 2H, P–C6H5-meta), 7.47 (t,
3
3
3
3
JHH = 7.4 Hz, 1H, P–C6H5-para), 7.83 (dd, JPH = 12.2 Hz, 2H,
13
JHH = 8.0 Hz, P–C6H5-ortho). C NMR (CDCl3, ppm): δ 24.28 (d,
3
JPC = 4.9 Hz, CH3), 24.35 (d, JPC = 6.4 Hz, CH3), 41.43 (s, CH),
SnCl (CH ) {C H P(O)[NHC(CH ) ] } (2)
2
3 2
6
5
3 3 2
3
4
1
26.65 (d, JPC = 13.1 Hz, P–C6H5-meta), 129.61 (d, JPC = 2.3 Hz,
To a stirred solution of C6H5P(O)[NHC(CH3)3]2 (132 mg, 0.5 mmol),
a solution of (CH3)2SnCl2 (54 mg, 0.25 mmol) in 10 ml of toluene
was added and heated (50–60 C) for 2 h. The resulting mixture
was then stirred at room temperature overnight. The mixture was
filtered and the solvent was evaporated to give a white powder.
Recrystallization of the powder in dichloromethane–hexane (1 : 1,
v/v) mixture produced single crystals of 2.
2
P–C6H5-para), 130.05 (d, JPC = 9.3 Hz, P–C6H5-ortho), 132.70 (d,
1
31
JPC = 150.9 Hz, P–C6H5-ipso). P NMR (CDCl3, ppm): δ 17.82 (m).
◦
−
1
IR (KBr, cm ): ν = 3200 (s, NH), 2940 (m), 1459 (m), 1427 (m), 1379
(w), 1180 (s, P O), 1158 (s), 1137 (s), 1110 (m), 1039 (s), 1006 (m),
9
02 (m, P–N), 870 (w), 839 (w), 740 (m), 689 (m), 551 (m), 517 (m).
◦
Synthesis of C6H5P(O)[NHC(CH3)3]2
M.p. 167 C. Anal. calcd for C H Cl N OPSn: C; 39.38; H, 6.40;
1
6
31
2 2
1
N, 5.74%. Found: C; 39.39; H, 6.40; N, 5.72%. H NMR (CDCl3, ppm):
This ligand was prepared by a modified procedure given in the
literature.[ To a 20 ml CH3CN solution of PhP(O)Cl2 (0.688 g,
2
119/117
1
δ 1.21 [6H, J(
Sn, H) = 81.7 Hz, Sn(CH3)2], 1.30 (s, 18H, CH3),
8]
2
3
4
2
2
(
(
(
.55 (d, 2H, JPH = 10.1 Hz, NH), 7.45 (td, JHH = 7.7 Hz, JPH = 4.3,
3
1
.53 mmol) was added a solution of tert-butylamine (1.03 g,
4.12 mmol) in CH3CN (10 ml) dropwise with continuous stirring
3
H, P–C6H5-meta), 7.49 (dt, JHH = 7.7 Hz, 1H, P–C6H5-para), 7.85
3
3
13
dd, JPH = 13.5 Hz, JHH = 6.75 Hz, 2H, P–C6H5-ortho). C NMR
in an ice bath. After 12 h stirring at room temperature the solvent
was removed, and the product was washed with distilled water
and dried (yield 0.605 g, 64%).
1 119 13
CDCl3, ppm): δ 13.30 (s, SnCH3), J( Sn, C) = 665.1 Hz) 32.01
3
3
d, JPC = 4.3 Hz, CH3), 52.23 [s, C(CH3)3], 128.42 (d, JPC = 13.7,
2
◦
P–C6H5-meta),131.50(d, JPC = 10.6 Hz,P–C6H5-ortho),131.63(d,
M.p.182 C.Anal.calcdforC14H25N2OP:C,62.66;H,9.39;N,10.44.
4
1
JPC = 2.4 Hz, P–C6H5-para), 135.44 (d, JPC = 157.7 Hz, P–C6H5-
1
Found: C, 62.62; H, 9.41; N, 10.5%. H NMR (CDCl3, ppm): δ 1.28 (s,
3
1
1
ipso). P NMR (CDCl3, ppm): δ 15.04 (s). H NMR (DMSO-d6, ppm):
2
1
8H,CH3),2.38(d,2H, JPH = 9.1 Hz,NH),7.40(m,3H,P–C6H5-para,
2
119/117
1
δ 1.03 [6H, J(
Sn, H) = 112.9 Hz, Sn(CH3)2], 1.14 (s, 18H,
3
3
meta), 7.82 (m, JPH = 12.7 Hz, JHH = 7.6 Hz, 2H, P–C6H5-ortho).
2
CH3), 3.77 (d, 2H, JPH = 8.8 Hz, NH), 7.39 (m, 3H, P–C6H5-para,
1
3
3
C NMR (CDCl3, ppm): δ 32.02 (d, JPC = 4.2 Hz, CH3), 51.78
1
3
meta), 7.75 (m, 2H, P–C6H5-ortho). C NMR (DMSO-d6, ppm):
3
[
s, C (CH3)3], 128.01(d, JPC = 13.3 Hz, P–C6H5-meta), 130.71 (d,
1
119
13
1
117
13
δ 23.15 [s, Sn–CH3, J( Sn, C) = 1005.7 Hz, J( Sn, C)
4
2
JPC = 2.4 Hz, P–C6H5-para), 131.43 (d, JPC = 9.5 Hz, P–C6H5-
3
=
956.3 Hz], 31.58 (d, JPC = 4.2 Hz, CH3), 50.60 [s, C(CH3)3],
1
31
ortho), 137.74 (d, JPC = 156.3 Hz, P–C6H5-ipso). P NMR (CDCl3,
3
4
1
27.46 (d, JPC = 12.8 Hz, P–C6H5-meta), 129.83 (d, JPC = 2.3 Hz,
1
ppm): δ 14.77 (broad). H NMR (DMSO-d6, ppm): δ 1.14 (s, 18H,
2
P–C6H5-para), 131.31 (d, JPC = 9.5 Hz, P–C6H5-ortho), 139.4 (d,
2
3
CH3), 3.79 (d, 2H, JPH = 9.1 Hz, NH), 7.39 (m, JHH = 6.7 Hz, 3H,
1
31
JPC = 148.5 Hz, P–C6H5-ipso). P NMR (DMSO-d6, ppm): δ 13.60
3
3
P–C6H5-para, meta), 7.74 (dd, JPH = 12.2 Hz, JHH = 7.7 Hz, 2H,
2
119
119
(
(
(
m, JPH = 9.4 Hz). Sn NMR (DMSO-d6, ppm): −238.2 Sn NMR
1
3
3
P–C6H5-ortho). CNMR(DMSO-d6,ppm):δ 31.61(d, JPC = 4.1 Hz,
−1
CD3OD, ppm): δ −106.62. IR (KBr, cm ): ν = 3410 (m, NH), 3235
3
CH3), 50.62 [s, C(CH3)3], 127.50 (d, JPC = 12.7 Hz, P–C6H5-meta),
m, NH), 2905 (s), 1469 (w), 1431 (m), 1361 (m), 1225 (s), 1187 (s),
4
2
1
29.85 (d, JPC = 2.6 Hz, P–C6H5-para), 131.34 (d, JPC = 9.5 Hz,
1
(
146 (s, P O), 1115 (s), 1040 (m), 1009 (s), 860 (w), 787 (w), 729
w), 707 (w), 570 (m), 565 (w, Sn–C), 436 (w, Sn–O).
1
3
1
P–C6H5-ortho), 139.43 (d, JPC = 148.6 Hz, P–C6H5-ipso). P NMR
DMSO-d6, ppm): δ 13.61 (m, JPH = 9.8 Hz). IR (KBr, cm ):
ν = 3390 (w, NH), 3210 (m, NH), 3205 (w), 2980 (m), 1462 (w),
424 (m), 1380 (m), 1219 (s, P O), 1182 (s), 1115 (m), 1006 (s), 857
w), 749 (w), 724 (w), 570 (m), 539 (w).
2
−1
(
Crystal Structure Determination
1
(
X-ray data of compounds 1 and 2 were collected on a Bruker
SMART 1000 CCD area detector[ with graphite-monochromated
Mo Kα radiation (k = 0.71073 Å). The structures were refined with
9]
Synthesis of complexes 1 and 2
SHELXL-97[ by full-matrix least squares on F . The positions
of hydrogen atoms were obtained from the difference Fourier
map. Crystal data and experimental details of the structure
determinations are listed in Table 2.
10]
2
SnCl2(CH3)2{C6H5P(O)[NHCH(CH3)2]2}2 (1)
Dimethyltin dichloride (70 mg, 0.32 mmol) was added to an
acetonitrile solution (10 ml) of C6H5P(O)[NHCH(CH3)2]2 (152 mg,
0
.64 mmol) and stirred at room temperature. After 10 days, the
In Vitro Antibacterial Activity
solvent was allowed to evaporate slowly and the suitable single
crystals of 1 were obtained after 5 days (yield 80 mg, 71%).
The in vitro antibacterial activities of the ligands and their
◦
M.p. 134 C. Anal. calcd for C26H48Cl2N4O2P2Sn: C, 44.60; H, 6.91;
organotin (IV) derivatives were tested by using the filter pa-
1
[11]
N, 8.00. Found: C, 44.56; H, 6.90; N, 7.98%. H NMR (CDCl3, ppm):
per disk method.
The bacteria were cultured in nutrient agar
Appl. Organometal. Chem. 2010, 24, 700–707
Copyright ꢀc 2010 John Wiley & Sons, Ltd.
wileyonlinelibrary.com/journal/aoc